Aldrich A, Bosch ME, Fallet R, Odvody J, Burkovetskaya M, Rama Rao K et al (2016) Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3). Ann Neurol 80(6):909–923

CAS  PubMed  PubMed Central  Google Scholar 

Anderson GW, Goebel HH, Simonati A (2013) Human pathology in NCL. Biochim Biophys Acta 1832(11):1807–1826

CAS  PubMed  Google Scholar 

Augustine EF, Adams HR, de Los Reyes E, Drago K, Frazier M, Guelbert N et al (2021) Management of CLN1 disease: international clinical consensus. Pediatr Neurol 120:38–51

PubMed  Google Scholar 

Baekmann C, Handrup MM, Molgaard H, Ejerskov C, Jensen HK, Ostergaard JR (2024) Insight of autonomic dysfunction in CLN3 disease: a study on episodes resembling paroxysmal sympathetic hyperactivity (PSH). Orphanet J Rare Dis 19(1):374

CAS  PubMed  PubMed Central  Google Scholar 

Barney CC, Hoch J, Byiers B, Dimian A, Symons FJ (2015) A Case-controlled investigation of pain experience and sensory function in neuronal ceroid lipofuscinosis. Clin J Pain 31(11):998–1003

PubMed  PubMed Central  Google Scholar 

Bosch ME, Aldrich A, Fallet R, Odvody J, Burkovetskaya M, Schuberth K et al (2016) Self-Complementary AAV9 gene delivery partially corrects pathology associated with juvenile neuronal ceroid lipofuscinosis (CLN3). J Neurosci 36(37):9669–9682

CAS  PubMed  PubMed Central  Google Scholar 

Bosch-Queralt M, Fledrich R, Stassart RM (2023) Schwann cell functions in peripheral nerve development and repair. Neurobiol Dis 176:105952

CAS  PubMed  Google Scholar 

Burkovetskaya M, Karpuk N, Xiong J, Bosch M, Boska MD, Takeuchi H et al (2014) Evidence for aberrant astrocyte hemichannel activity in juvenile neuronal ceroid lipofuscinosis (JNCL). PLoS ONE 9(4):e95023

PubMed  PubMed Central  Google Scholar 

Cooper JD, Tarczyluk MA, Nelvagal HR (2015) Towards a new Understanding of NCL pathogenesis. Biochim Biophys Acta 1852(10 Pt B):2256–2261

CAS  PubMed  Google Scholar 

Cotman SL, Vrbanac V, Lebel LA, Lee RL, Johnson KA, Donahue LR et al (2002) Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth. Hum Mol Genet 11(22):2709–2721

CAS  PubMed  Google Scholar 

Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW et al (2007) AAV vector integration sites in mouse hepatocellular carcinoma. Science 317(5837):477

CAS  PubMed  Google Scholar 

Falk DJ, Todd AG, Lee S, Soustek MS, ElMallah MK, Fuller DD et al (2015) Peripheral nerve and neuromuscular junction pathology in Pompe disease. Hum Mol Genet 24(3):625–636

CAS  PubMed  Google Scholar 

Griffey MA, Bible E, Vogler C, Levy B, Gupta P, Cooper JD et al (2004) Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis. Neurobiol Dis 16(2):360–369

CAS  PubMed  Google Scholar 

Griffey M, Macauley SL, Ogilvie JM, Sands MS (2005) AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis. Mol Ther 12(3):413–421

CAS  PubMed  Google Scholar 

Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM et al (2006) CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 13(3):538–547

CAS  PubMed  Google Scholar 

Hachiya Y, Hayashi M, Kumada S, Uchiyama A, Tsuchiya K, Kurata K (2006) Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses. Acta Neuropathol 111(2):168–177

CAS  PubMed  Google Scholar 

Handrup MM, Mølgaard H, Andersen BN, Ostergaard JR (2022) Pacemaker implantation in juvenile neuronal ceroid lipofuscinosis (CLN3)-A Long-Term Follow-Up study. Front Neurol 13:846240

PubMed  PubMed Central  Google Scholar 

Hastings RL, Valdez G (2024) Origin, identity, and function of terminal Schwann cells. Trends Neurosci 47(6):432–446

CAS  PubMed  PubMed Central  Google Scholar 

Hunter DA, Moradzadeh A, Whitlock EL, Brenner MJ, Myckatyn TM, Wei CH et al (2007) Binary imaging analysis for comprehensive quantitative histomorphometry of peripheral nerve. J Neurosci Methods 166(1):116–124

PubMed  PubMed Central  Google Scholar 

Hunter DA, Pan D, Wood MD, Snyder-Warwick AK, Moore AM, Feldman EL et al (2020) Design-Based stereology and binary image histomorphometry in nerve assessment. J Neurosci Methods 336:108635

PubMed  PubMed Central  Google Scholar 

Johnson TB, Cain JT, White KA, Ramirez-Montealegre D, Pearce DA, Weimer JM (2019) Therapeutic landscape for Batten disease: current treatments and future prospects. Nat Rev Neurol 15:161–178

PubMed  PubMed Central  Google Scholar 

Johnson TB, Brudvig JJ, Likhite S, Pratt MA, White KA, Cain JT et al (2023) Early postnatal administration of an AAV9 gene therapy is safe and efficacious in CLN3 disease. Front Genet 14:1118649. https://doi.org/10.3389/fgene.2023.1118649

CAS  PubMed  PubMed Central  Google Scholar 

Kohlschütter A, Schulz A, Bartsch U, Storch S (2019) Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs 33(4):315–325

PubMed  PubMed Central  Google Scholar 

Kovács AD, Saje A, Wong A, Szénási G, Kiricsi P, Szabó E et al (2011) Temporary Inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease. Neuropharmacology 60(2–3):405–409

PubMed  Google Scholar 

Kovács AD, Saje A, Wong A, Ramji S, Cooper JD, Pearce DA (2012) Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease. Neuropharmacology 63(5):769–775

PubMed  PubMed Central  Google Scholar 

Laqtom NN, Dong W, Medoh UN, Cangelosi AL, Dharamdasani V, Chan SH et al (2022) CLN3 is required for the clearance of glycerophosphodiesters from lysosomes. Nature 609(7929):1005–1011

CAS  PubMed  PubMed Central  Google Scholar 

Lerner TJ, Boustany R-M, Anderson JW, D’arigo KL, Schlumpf K, Buckler A et al (1995) Isolation of a novel gene underlying Batten disease, CLN3. Cell 82(6):949–957

Google Scholar 

Levine AS, Lemieux B, Brunning R, White JG, Sharp HL, Stadlan E et al (1968) Ceroid accumulation in a patient with progressive neurological disease. Pediatrics 42(3):583–591

CAS  PubMed  Google Scholar 

Lim MJ, Alexander N, Benedict JW, Chattopadhyay S, Shemilt SJ, Guérin CJ et al (2007) IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol Dis 25(2):239–251

CAS  PubMed  Google Scholar 

Lovering RM, Iyer SR, Edwards B, Davies KE (2020) Alterations of neuromuscular junctions in Duchenne muscular dystrophy. Neurosci Lett 737:135304

CAS  PubMed  PubMed Central  Google Scholar 

Macauley SL, Roberts MS, Wong AM, McSloy F, Reddy AS, Cooper JD et al (2012) Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis. Ann Neurol 71(6):797–804

CAS  PubMed  PubMed Central  Google Scholar 

Macauley SL, Wong AM, Shyng C, Augner DP, Dearborn JT, Pearse Y et al (2014) An anti-neuroinflammatory that targets dysregulated glia enhances the efficacy of CNS-directed gene therapy in murine infantile neuronal ceroid lipofuscinosis. J Neurosci 34(39):13077–13082

CAS  PubMed  PubMed Central  Google Scholar 

Mannerkoski MK, Heiskala HJ, Santavuori PR, Pouttu JA (2001) Transdermal Fentanyl therapy for pains in children with infantile neuronal ceroid lipofuscinosis. Eur J Paediatr Neurol 5(Suppl A):175–177

PubMed  Google Scholar 

Mole SE, Anderson G, Band HA, Berkovic SF, Cooper JD, Kleine Holthaus SM et al (2019) Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis. Lancet Neurol 18:107–116

PubMed  Google Scholar 

Mole SE, Schulz A, Badoe E, Berkovic SF, de Los Reyes EC, Dulz S et al (2021) Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients. Orphanet J Rare Dis 16(1):185

PubMed  PubMed Central  Google Scholar 

Moro F, Rubegni A, Pochiero F, Mero S, Procopio E, Baldacci J et al (2019) Autophagic vacuolar myopathy caused by a CLN3 mutation. A case report. Neuromuscul Disord 29(1):67–69

PubMed  Google Scholar